Duratia 60 Mg is generally associated with dapoxetine, a selective serotonin reuptake inhibitor (SSRI) primarily used in some countries for the treatment of premature ejaculation (PE). It is not a standard treatment for erectile dysfunction (ED), and the product's active ingredient should be verified on its packaging.
Dapoxetine works mainly by affecting serotonin signaling in the nervous system. By increasing serotonin activity, it can help improve control over ejaculation and may increase the time before ejaculation in appropriate men with PE. Unlike PDE5 inhibitors such as sildenafil or tadalafil, dapoxetine does not directly increase blood flow to the penis and therefore should not be considered an ED medicine.
Men experiencing both ED and PE may require separate evaluation because these are different conditions and can have different underlying causes. A healthcare professional can determine whether dapoxetine, an ED treatment, or another approach is appropriate.
Common side effects associated with dapoxetine include nausea, dizziness, headache, diarrhea, and difficulty sleeping. Dizziness or fainting can occur, particularly because of blood-pressure changes, so medical advice is important before use.
Dapoxetine can interact with several medicines, including certain antidepressants and other drugs that affect serotonin. It should not be combined with other serotonergic medicines unless specifically approved by a healthcare professional.
If erectile difficulties persist, medical evaluation can help identify contributing factors such as cardiovascular disease, diabetes, medication effects, stress, or hormonal conditions.
Therefore, Duratia 60 Mg should not be described as a medicine that directly treats erectile dysfunction. Its commonly associated active ingredient, dapoxetine, is intended primarily for premature ejaculation, and treatment should be based on the confirmed product formulation and professional medical advice.
